Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Oder

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinical Genetics|March 10, 2018
The D313Y genotype-Pathogenic mutation or polymorphism?D Oder, C Wanner, P Nordbeck
The Journal of Trauma|December 29, 2000
An evidence-based cost-effectiveness model on methods of prevention of posttraumatic venous thromboembolismG C Velmahos, Y Oh, J McCombs, et al.
Clinical Radiology|February 13, 2001
MR imaging of bone oedema: mechanisms and interpretationS Eustace, C Keogh, M Blake, et al.
Evidence Report/Technology Assessment (Summary)|April 3, 2002
Prevention of venous thromboembolism after injuryG C Velmahos, J Kern, L Chan, et al.
The Journal of Trauma|July 27, 2000
Prevention of venous thromboembolism after injury: an evidence-based report--part I: analysis of risk factors and evaluation of the role of vena caval filtersG C Velmahos, J Kern, L S Chan, et al.
The Journal of Trauma|July 27, 2000
Prevention of venous thromboembolism after injury: an evidence-based report--part II: analysis of risk factors and evaluation of the role of vena caval filtersG C Velmahos, J Kern, L S Chan, et al.
New Horizons (Baltimore, Md.)|November 1, 1996
Use of large databases for resolving critical care problemsH Belzberg, J Murray, W C Shoemaker, et al.
Journal of Internal Medicine|July 7, 2017
Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry diseaseM Lenders, D Oder, A Nowak, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical Genetics|March 10, 2018
The D313Y genotype-Pathogenic mutation or polymorphism?D Oder, C Wanner, P Nordbeck
The Journal of Trauma|December 29, 2000
An evidence-based cost-effectiveness model on methods of prevention of posttraumatic venous thromboembolismG C Velmahos, Y Oh, J McCombs, et al.
Clinical Radiology|February 13, 2001
MR imaging of bone oedema: mechanisms and interpretationS Eustace, C Keogh, M Blake, et al.
Evidence Report/Technology Assessment (Summary)|April 3, 2002
Prevention of venous thromboembolism after injuryG C Velmahos, J Kern, L Chan, et al.
The Journal of Trauma|July 27, 2000
Prevention of venous thromboembolism after injury: an evidence-based report--part I: analysis of risk factors and evaluation of the role of vena caval filtersG C Velmahos, J Kern, L S Chan, et al.
The Journal of Trauma|July 27, 2000
Prevention of venous thromboembolism after injury: an evidence-based report--part II: analysis of risk factors and evaluation of the role of vena caval filtersG C Velmahos, J Kern, L S Chan, et al.
New Horizons (Baltimore, Md.)|November 1, 1996
Use of large databases for resolving critical care problemsH Belzberg, J Murray, W C Shoemaker, et al.
Journal of Internal Medicine|July 7, 2017
Impact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry diseaseM Lenders, D Oder, A Nowak, et al.
Pageof 1